Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Domenica Lorusso, MD, PhD, of the IRCCS National Cancer Institute, Milan, Italy, discusses the poor diagnostics for ovarian cancer, at the European Society for Medical Oncology (ESMO) 2018 Congress, in Munich, Germany. Preventative BRCA testing, for patients and extended family, is currently the best prognostic tool.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.